Zepbound, Ozempic, and Wegovy are weight loss and blood sugar management medications. Zepbound contains tirzepatide, a dual GLP-1 and GIP receptor agonist, while Ozempic and Wegovy contain semaglutide, a GLP-1 agonist. Zepbound targets both GLP-1 and GIP receptors, while Ozempic is mainly for type 2 diabetes, and Wegovy is specifically approved for weight loss.